UEG Week 2020 Oral Presentations
, 2020 United European Gastroenterology Journal, Volume 8, Issue S8, Page 8-142, October 2020.
wiley +1 more source
, 2017 The Raw 264.7 cells were treated with or without LPS (1 μg/ml) for 6 h and then stimulated with MSU crystals for another 6 h. Figure S2. The levels of ROS were assessed by calculating the ratio of positive-staining cells among 10,000 cells using flow cytometry. Raw 264.7 cells were treated with procyanidins (10 μM) for 20 min and then stimulated by MSU
Liu, Hai-Jiao +9 more
openaire +1 more source
UEG Week 2024 Oral Presentations
United European Gastroenterology Journal, Volume 12, Issue S8, Page 9-200, October 2024.
wiley +1 more source
A common mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout [PDF]
Arthritis & Rheumatism, 2005 Atsuo, Taniguchi +6 more
openaire +2 more sources
Suppression of the shunt pathway in primary gout by azathioprine. [PDF]
Proceedings of the National Academy of Sciences, 1966 openaire +2 more sources
Preinfusion Glucocorticoid Reduction and Elimination in Patients With Uncontrolled Gout on Pegloticase and Methotrexate: A Case Series. [PDF]
J Clin RheumatolAlbert J +3 more
europepmc +1 more source
Gout prevalence and management strategies among patients with moderate to advanced chronic kidney disease. [PDF]
J Bras NefrolSylvertooth D +5 more
europepmc +1 more source
Treatment sequence patterns of urate-lowering therapy in Korean patients with gout: A common data model-based study. [PDF]
PLoS OneKim MJ +5 more
europepmc +1 more source
Allopurinol-induced drug reaction with eosinophilia and systemic symptoms syndrome in a patient with previous nephrectomy: a case report. [PDF]
J Med Case RepFerrie S, Khandaker M.
europepmc +1 more source
Relation of Colchicine to Total Joint Arthroplasty Among People With Gout in a Population-Based Cohort Study. [PDF]
Arthritis RheumatolWang Z +5 more
europepmc +1 more source